These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32470270)

  • 1. [Osteoporosis-pseudoglioma Syndrome: a pediatric case of primary osteoporosis].
    Braslavsky D; Scaglia P; Sanguineti N; Aza-Carmona M; Nevado Blanco J; Lapunzina Badia PD; Fernández MDC; Ruiz O; Carmona A; Szlago M; Arberas C; Cassinelli H; Heath K; Rey R; Bergadá I
    Arch Argent Pediatr; 2020 Jun; 118(3):e300-e304. PubMed ID: 32470270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoporosis-pseudoglioma syndrome: clinical, genetic, and treatment-response study of 10 new cases in Greece.
    Papadopoulos I; Bountouvi E; Attilakos A; Gole E; Dinopoulos A; Peppa M; Nikolaidou P; Papadopoulou A
    Eur J Pediatr; 2019 Mar; 178(3):323-329. PubMed ID: 30499050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Homozygous LRP5 Mutations in Mexican Patients with Osteoporosis-Pseudoglioma Syndrome.
    Astiazarán MC; Cervantes-Sodi M; Rebolledo-Enríquez E; Chacón-Camacho O; Villegas V; Zenteno JC
    Genet Test Mol Biomarkers; 2017 Dec; 21(12):742-746. PubMed ID: 29131652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical femoral fracture in osteoporosis pseudoglioma syndrome associated with two novel compound heterozygous mutations in LRP5.
    Alonso N; Soares DC; V McCloskey E; Summers GD; Ralston SH; Gregson CL
    J Bone Miner Res; 2015 Apr; 30(4):615-20. PubMed ID: 25384351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis-pseudoglioma syndrome: Report of two cases and a manifesting carrier.
    Maltese P; Ziccardi L; Iarossi G; Gusson E; D'Agruma L; Marchini G; Buzzonetti L; Nicoletti A; Benedetti S; Bertelli M
    Ophthalmic Genet; 2017; 38(5):473-479. PubMed ID: 28145787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mutations in the LRP5 gene in patients with Osteoporosis-pseudoglioma syndrome.
    Pekkinen M; Grigelioniene G; Akin L; Shah K; Karaer K; Kurtoğlu S; Ekbote A; Aycan Z; Sağsak E; Danda S; Åström E; Mäkitie O
    Am J Med Genet A; 2017 Dec; 173(12):3132-3135. PubMed ID: 29055141
    [No Abstract]   [Full Text] [Related]  

  • 7. Congenital Bilateral Retinal Detachment in Two Siblings with Osteoporosis-Pseudoglioma Syndrome.
    Welinder LG; Robitaille JM; Rupps R; Boerkoel CF; Lyons CJ
    Ophthalmic Genet; 2015; 36(3):276-80. PubMed ID: 25945592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features, treatment, and follow-up of OPPG and high-bone-mass disorders: LRP5 is a key regulator of bone mass.
    Ren N; Lv S; Li X; Shao C; Wang Z; Mei Y; Yang W; Fu W; Hu Y; Sha L; Hu W; Zhang Z; Wang C
    Osteoporos Int; 2024 Aug; 35(8):1395-1406. PubMed ID: 38625381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis-pseudoglioma syndrome: three novel mutations in the LRP5 gene and response to bisphosphonate treatment.
    Tüysüz B; Bursalı A; Alp Z; Suyugül N; Laine CM; Mäkitie O
    Horm Res Paediatr; 2012; 77(2):115-20. PubMed ID: 22456437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and biochemical response to neridronate treatment in a patient with osteoporosis-pseudoglioma syndrome (OPPG).
    Celli M; D'Eufemia P; Persiani P; Turchetti A; Febbo A; D'Alfonso Y; Celli L; Zambrano A
    Osteoporos Int; 2017 Nov; 28(11):3277-3280. PubMed ID: 28866852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable Expressivity and Response to Bisphosphonate Therapy in a Family with Osteoporosis Pseudoglioma Syndrome.
    Tallapaka KB; Ranganath P; Dalal A
    Indian Pediatr; 2017 Aug; 54(8):681-683. PubMed ID: 28891484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRP5-linked osteoporosis-pseudoglioma syndrome mimicking isolated microphthalmia.
    Ergun SG; Akay GG; Ergun MA; Perçin EF
    Eur J Med Genet; 2017 Mar; 60(3):200-204. PubMed ID: 28111184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy-associated osteoporosis with a heterozygous deactivating LDL receptor-related protein 5 (LRP5) mutation and a homozygous methylenetetrahydrofolate reductase (MTHFR) polymorphism.
    Cook FJ; Mumm S; Whyte MP; Wenkert D
    J Bone Miner Res; 2014 Apr; 29(4):922-8. PubMed ID: 24014470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis-pseudoglioma syndrome in four new patients: identification of two novel LRP5 variants and insights on patients' management using bisphosphonates therapy.
    Abdel-Hamid MS; Elhossini RM; Otaify GA; Abdel-Ghafar SF; Aglan MS
    Osteoporos Int; 2022 Jul; 33(7):1501-1510. PubMed ID: 35106624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploiting the WNT Signaling Pathway for Clinical Purposes.
    Johnson ML; Recker RR
    Curr Osteoporos Rep; 2017 Jun; 15(3):153-161. PubMed ID: 28432596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential blindness in children of patients with hereditary bone disease.
    Kheir V; Munier FL; Aubry-Rozier B; Schorderet DF
    Osteoporos Int; 2016 Feb; 27(2):841-4. PubMed ID: 26243358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Homozygous Nonsense Mutation in the
    Heidari A; Homaei A; Saffari F
    J Clin Res Pediatr Endocrinol; 2023 Aug; 15(3):318-323. PubMed ID: 34965700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity.
    Korvala J; Jüppner H; Mäkitie O; Sochett E; Schnabel D; Mora S; Bartels CF; Warman ML; Deraska D; Cole WG; Hartikka H; Ala-Kokko L; Männikkö M
    BMC Med Genet; 2012 Apr; 13():26. PubMed ID: 22487062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG).
    Laine CM; Chung BD; Susic M; Prescott T; Semler O; Fiskerstrand T; D'Eufemia P; Castori M; Pekkinen M; Sochett E; Cole WG; Netzer C; Mäkitie O
    Eur J Hum Genet; 2011 Aug; 19(8):875-81. PubMed ID: 21407258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders.
    Levasseur R; Lacombe D; de Vernejoul MC
    Joint Bone Spine; 2005 May; 72(3):207-14. PubMed ID: 15850991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.